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In vitro models that better reflect in vivo epithelial barrier (patho-)physiology are urgently
required to predict adverse drug effects. Here we introduce extracellular matrix-supported
intestinal tubules in perfused microfluidic devices, exhibiting tissue polarization and
transporter expression. Forty leak-tight tubules are cultured in parallel on a single plate and
their response to pharmacological stimuli is recorded over 125 h using automated imaging
techniques. A study comprising 357 gut tubes is performed, of which 93% are leak
tight before exposure. EC50-time curves could be extracted that provide insight into both
concentration and exposure time response. Full compatibility with standard equipment and
user-friendly operation make this Organ-on-a-Chip platform readily applicable in routine
laboratories.
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Dysfunction of epithelial barriers as a result of pathologicalstates or drug-induced toxicity can lead to life-threateningconditions and halt drug development at all clinical
stages. Epithelial barrier disruption is mainly manifested by an
increased para-cellular permeability of the epithelium. In vitro
testing of para-cellular permeability of epithelial barriers is most
commonly achieved by cultivating cells on a rigid membrane
that separates two medium-containing chambers under static
conditions. Such conventional Transwell systems are poorly
suited for high-resolution kinetic measurements and image-based
readouts, and therefore provide only limited information on the
underlying mechanisms, leading to barrier disruption. More
importantly, it does not comply with the current paradigm in
cell culture that is steadily shifting towards three-dimensional
cultures, extracellular matrix (ECM) embedment and addition of
perfusion flow1–5.
The field of microfluidics has rapidly gained momentum in the
realm of in vitro modeling3. Inherent to its dimensions,
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Fig. 1 Overview of the method for modeling intestinal tubules in the OrganoPlate platform. a Photograph of the bottom of an OrganoPlate showing 40
microfluidic channel networks with inlay showing the top view of the 384-well plate format device; b Zoom-in on a single microfluidic channel network
comprising three channels that join in the center. c, e, g, i Horizontal projection and d, f, h, j vertical cross section of center region for subsequent steps in
establishing the gut model. c, d An extracellular matrix gel (light gray) is patterned by two phaseguides (dark gray), e, f culture medium is introduced in the
two lanes adjacent to the ECM gel, one of which comprises cells. g, h Cells are allowed to settle against the ECM gel surface by placing the plate on its side.
i, j Upon application of flow, cells form a confluent layer lining the channel and gel surfaces, resulting in a tubular shape. k 3D artist impression of the center
of a chip comprising a tubule, an extra cellular matrix gel and a perfusion lane; two phaseguides (white bars) are present that define the three distinct lanes
in the central channel. The tubule has a lumen at its apical side that is perfused. l–p Phase-contrast images of the formation of the tubular structure at day
0, 1, 4, 7, and 11, respectively. Scale bars are 100 µm
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00259-3
2 NATURE COMMUNICATIONS | 8:  262 |DOI: 10.1038/s41467-017-00259-3 |www.nature.com/naturecommunications
microfluidic techniques are uniquely suitable to connect with
epithelia of tubular shapes in order to provide shear stress and
continuous medium refreshment through perfusion. Typical
microfluidic solutions make use of artificial membranes to enable
apical-basal access to the epithelia6, thus not accommodating an
ECM that is a crucial parameter in cell signaling involved in
differentiation and epithelial-to-mesenchymal transition. Also,
microfluidic techniques, which are typically presented as single
chips7, need to be parallelized in order to deliver readouts
for multiple compounds, dilutions, replicates and controls.
User-friendly operation and compatibility with state-of-the-art
readouts, such as high content imaging (HCI)-based multiplexed
cellular and molecular analyses, are crucial prerequisites for
perfused, ECM-embedded cell culture techniques to become a
new standard.8
We developed a methodology to culture perfused,
ECM-supported epithelia and interrogate their barrier function in
a membrane-free manner. As an example, we developed a model
of intestinal tract epithelium that exhibits cellular polarization,
tight junction formation, and expression of key receptors. Forty
gut models were grown in a tubular shape in the OrganoPlate
platform that was accessible from both the apical and basal sides.
The tubes were assessed for barrier integrity and exposed to
staurosporine and acetylsalicylic acid (aspirin) for 125 h. From
330 tubes used in these experiments, 93% were leak tight before
exposure. The experiment was repeated using real-time parallel
time-lapse imaging, in which tubes were stable up till 6 to 8 h.
EC50-time curves provide insight in concentration response at
increasing exposure time in one single experimental run.
Results
Intestinal tube culture in OrganoPlate. Figure 1 shows the
OrganoPlate platform, which encompasses 40 microfluidic cell
culture structures embedded in a standard 384-well microtiter
plate format (Fig. 1a, b)9, 10. Each microfluidic channel structure
is comprised of three lanes that are connected to corresponding
wells of a microtiter plate that function as inlets and outlets
to access the microfluidic culture. The lanes join in the centre
of the structure where two capillary pressure barriers are
present called phaseguides11. Figure 1c–j shows a schematic
representation of vertical and horizontal cross-sections of the
centre of a microfluidic structure and the method of growing a
tubular structure. First, an ECM gel is introduced in the central
lane (Fig. 1c, d). The phaseguides are used to selectively pattern
the ECM gel in the central lane by meniscus pinning. The
meniscus stretches beyond the phaseguide, leading to a curved
shape. After ECM gelation, epithelial cells are seeded in one
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Fig. 2 Tubule characterization by immunofluorescent staining. a 3D reconstruction of a confocal z-stack showing tubular morphology with a lumen. White
arrows indicate the apical (A) and basal (B) sides. The tube is stained for tight junctions (ZO-1 in red) and brush borders (ezrin in green). b Max projection
and c vertical cross-section of the tubular structure in a; d, e zoom of the epithelial layer at the bottom of the tube exhibiting d tight junctions (ZO-1 in red)
and brush borders (ezrin in green), and e acetylated tubulin (green) and occluding (red). f Phase-contrast image showing dome formation. g Zoom of a
z-slice of the tube in a of the cell layer on top of the phaseguide showing apical positioning of ezrin, indicating polarization of the tube (white arrow indicates
basal side B). h Expression of glucose and MRP2 transporters, respectively stained with Glut-2 in red and MRP2 stain in green. Both Glut-2 and MRP2 show
significantly higher signal against the collagen gel compared to the regions that are not exposed to the collagen, indicating increased expression levels. Both
stains clearly stain the apical side of the tube. For z-slices above the phaseguide at a higher magnification see Supplementary Fig. 2b. i ErbB1 (red) and
acetylated tubulin (green) expression. ErbB1 expression levels appear higher against the collagen. j Co-staining of Glut-2 transporter and ErbB2 receptor;
both stains show higher signal levels against the collagen gel. ErbB2 is primarily expressed pericellularly (see also Supplementary Fig. 2d for a zoom)).
All tubes are fixed after 4 days in culture. Nuclei are stained blue with Draq5 (a–c, g–j) and DAPI (d, e). Scale bars in white are 100 µm with the exception of
d, e, f, and g, where they are 50 µm. Z-slices just above the phaseguide at higher magnification of the images g–j are available in Supplementary Fig. 2. All
images are representative of at least three biological and at least three technical replicates
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lateral lane, allowing them to sediment directly against the ECM
gel by placing the titre plate in a vertical position, i.e., standing on
one side (Fig. 1e–h). Upon attachment of the cells, the plate is
horizontally placed on an interval rocker that induces flow by
reciprocal leveling between reservoirs (Supplementary Fig. 1).
Upon application of flow, cells proliferate and start lining all
surfaces of the perfusion channel, forming a confluent tubular
structure (Fig. 1i, j). The tubules have a lumen that is connected
to the in- and outlet of the respective lanes, making then acces-
sible for perfusion with medium and for apical compound
exposure. The basal side of the epithelium is facing the ECM gel
and can be accessed by the second perfusion lane on the opposite
side of the ECM gel lane. Figure 1k depicts an artist impression of
the 3D configuration of the tube, showing that the tube is grown
directly against the ECM, without the presence of artificial
membranes (Fig. 1k).
For modeling of the intestinal barrier, the human intestinal
colorectal adenocarcinoma cell line (Caco-2) was used.
Figure 1l–p shows phase-contrast pictures of tube formation at
day 0, 1, 4, 7, and 11, respectively. On day 0, cells are seeded
against the ECM and start colonizing the glass walls to form a
confluent tube (Fig. 1n–p). Perfusion was crucial for tube
formation. Tubes were formed in 3 days and optimal barrier
function was found at day 4 (Supplementary Fig. 1).
Differentiation and polarization marker expression. Figure 2a
shows a 3D reconstruction of confocal fluorescence micrographs
of the gut tube. The tube has a clear lumen and lines the
perimeter of the gel and perfusion lane. Caco-2 cells in
the confluent tubule display tight junctions and brush border
formation as shown by immunofluorescence staining of ZO-1
and ezrin, respectively12 (Fig. 2a–d, g). Figure 2e shows
localization of acetylated tubulin (microtubules) and occludin
(tight junctions)13. Dome-formation is observed, indicative of
active fluid transport and intact epithelial barrier function14, 15
(Fig. 2f). Figure 2h–j shows maximum intensity projection images
of tubes stained for Glut-2, MRP2, ErbB1, and ErBb2. Cells in
contact with the ECM showed a strongly increased expression of
the transporters Glut-2, MRP2 and to a lesser extend ErbB1 and
ErbB2 receptors.16 These staining results illustrate the crucially
instructive role that the ECM plays in cellular differentiation and
protein expression. Furthermore, characteristics of the ECM gel
surface, such as its (bio-)chemical composition and mechanical
characteristics, allow the formation of tissue structures observed
in vivo.17 Polarization of the cell layer against the gel is best
visualized at the contact line between the gel meniscus and the
phaseguide, at the bending point of the cell layer where apical-
basal polarization is in the horizontal plane. This is the most
right-hand part of the tube in Fig. 2a or the bottom side of the
tube in Fig. 2b. Figure 2g and Supplementary Fig. 2 show single z-
slices at this bending point, just above the phaseguide. Tubes are
the same as the images of Fig. 2b, h–j, but depicted as single z-
slices and at higher magnification. Polarization is confirmed by
localization of brush borders (ezrin) and the MRP2 transporter
on the apical side as shown in Fig. 2g, and Supplementary Fig. 2a,
b, while ErBb2 is positioned pericellularly (see Supplementary
Fig. 2d). At least 10 Caco tubes were stained with each marker
that were grown on at least four different days for at least four
different passage numbers of cells prior to seeding. Figures show a
representative selection of results.
Barrier integrity. Barrier function of the Caco-2 tubes was
assessed by perfusion with a fluorescent probe in culture medium
through the tube lumen, followed by the determination of
fluorescence levels in the basal gel region, normalized to the
fluorescence in the lumen. This is illustrated in Fig. 3a–i. Both a
high molecular weight fluorescent probe (150 kDa FITC-dextran)
and a lower molecular weight probe (4.4 kDa TRITC-dextran)
were added to the medium that is perfused through the lumen of
the tube. In absence of an intact tubular structure, the fluorescent
probes leak into the gel and the basal side perfusion channel
(Fig. 3a, d, g), while for a fully intact barrier, the fluorescent
probes are retained in the lumen of the tube (Fig. 3b, e, h). Upon
(partial) loss of barrier function, e.g., through drug-induced
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Fig. 3 Barrier integrity assay in OrganoPlate. A fluorescent dye is inserted in the channel comprising the tube. Integrity of the tube barrier is quantified by
measuring the amount of dye that is leaking out of the tube into the adjacent gel channel. a–c Sketch in vertical cross section showing fluorescence
distribution: a in absence of a tube, b for the case of a leak-tight tube and c for a leaky tube. d–i Fluorescent images of microfluidic chips perfused with
fluorescent molecules show experimental results for: gel only (d, g), leak-tight tube (e, h), and leaky tube (f–i) using both 150 kDa FITC-dextran and 4.4
kDa TRITC-Dextran during the same experiment
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toxicity, the fluorescent probe leaks out of the lumen towards the
basal side, yielding a higher signal in the ECM (Fig. 3c, f, i).
Barrier integrity was measured using a HCI system, allowing
monitoring of 40 tubes in parallel. To quantify the integrity of
the barrier, the fluorescence level was measured in the gel region
and normalized to the fluorescence level in the luminal side to
compensate for bleaching effects. Upon reaching a fluorescence
value of 0.4, barrier integrity of a tube was considered lost.
The barrier integrity of 24 tubes was tracked on day 4, 7 and 11 of
culture. As depicted in Supplementary Fig. 1c, it was found that,
at day 4, all tubes were leak tight, while at day 7 and 11, three and
seven tubes were leaky, respectively. Therefore, barrier integrity
measurements are performed at 4 days of culture.
Drug-induced barrier disruption. Barrier integrity of 4-day-old
Caco-2 tubes was assessed during a 125-h apical exposure to
various concentrations of staurosporine (0.4–90 μM), an inducer
of apoptosis,18 and aspirin which affects tight junctions19
(0.16–40 mM). Fluorescence levels were measured at 1-h intervals
from 1 to 12 h, and 24 to 36 h, as well as at 16, 48, 53, 60, 72, 82,
96, and 125 h. Between measurements, the OrganoPlate
was placed back on the rocker platform to maintain flow.
Figure 4a–d depicts arrays of images showing the fluorescence in
the gel at each time-point for both FITC- and TRITC-dextran.
Measurements for each compound were taken on a single
OrganoPlate with five replicates per concentration. The
staurosporine and aspirin studies were executed five and
three times, respectively in separate experimental sessions (see
Supplementary Fig. 4).
Fluorescence images of one single OrganoPlate depicted in the
arrays of Fig. 4a–d and their quantification as depicted in Fig. 4e,
h show that barrier integrity gradually diminished over time for
all concentrations of staurosporine and for the two highest
concentrations of aspirin. Results can also be visualised by
generating Kaplan–Meier plots for loss of barrier integrity, in
which events are defined as the fluorescence ratio reaching 40%
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Fig. 4 Drug-induced loss of barrier integrity is observed over time in a concentration-dependent manner. Results shown for staurosporine (a, b, e–g) and
aspirin (c, d, h–j). a–d Array of fluorescence micrographs of the gel region showing distribution of the 150 kDa FITC-Dextran (a, c), and 4.4 kDa TRITC-
Dextran (b, d) over time and for various compound concentrations; the loss of barrier integrity results in an increased fluorescent signal. Measurements
are taken at 1-h intervals up to 12 h, at 16 h, from 24 to 36 h at 1 h interval, and at 48, 53, 60, 72, 82, 96, and 125 h. In between each interval, the
OrganoPlate was placed back into the incubator on the interval rocker platform to maintain the perfusion flow. Five technical replicates of each
concentration of a compound were measured on a single plate. One well was excluded from further data analysis, because of a pipetting error (marked with
“excl” in white). e, h The progression of the loss of barrier function over time is plotted as the ratio between fluorescent signal in apical and basal regions for
the various concentrations of staurosporine (e) and aspirin (h), where the plotted line is the mean of five replicate exposures and error bars depict the
standard deviation. f, i Kaplan–Meier curves were generated where survival was defined as showing a leakage score below 40%. Overlapping curves were
shifted by 1% for clarity purposes. g, j EC50 values are plotted as a function of exposure time. EC50 values were obtained by fitting a concentration-
response curve at each time point based on non-linear regression of leakage scores using normalized response and standard slope and were plotted
including 95% confidence interval (CI). EC50 values obtained from time points before the first event in the Kaplan–Meier plot, as indicated by a grayed out
line, should be interpreted with caution as the curve fit could be dominated by noise rather than biological effect. All shown graphs were derived from data
acquired using 150 kDa FITC dextran. Technical replicates are defined as tubes seeded on the same plate and exposed in the same experimental session.
Independent full replicate series were run for both staurosporine and aspirin that are displayed in Supplementary Figs. 3 and 4
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(Fig. 4f, i). This approach is particularly useful for less potent
toxicants, where EC50 determination suffers from a lack of data of
high effect. Aspirin, which has a different mode of action,
involving tight junction disruption and proliferation inhibition,
instead of apoptosis induction20, 21, causes much less barrier
disruption at relevant concentration. The Kaplan–Meier curve,
however, does show a highly significant trend of loss-of-barrier
function at higher concentration (P< 0.0001 for both curve
difference and trend significance, derived from log-rank tests)
(Fig. 4i). An EC50 value was estimated for each time point by
fitting the concentration-response curve based on non-linear
regression of the logarithm of the compound concentration vs.
the normalized fluorescence, assuming a top and bottom plateau
at 0 and 100% fluorescence. With increasing exposure times, a
shift of EC50 toward lower compound concentrations was
observed (Fig. 4g, j). The 95% confidence interval of the extracted
EC50 values indicates the robust data over the entire exposure
time. EC50 values extracted at time points before the first event in
the Kaplan–Meier plots should be interpreted with caution, as
baseline fluorescence is likely to dominate the curve fitting rather
than a biologically relevant signal.
Supplementary Fig. 3 shows an independent repeat of the study
in Fig. 4 using cells seeded at different passage numbers in
separate experimental sessions. Supplementary Fig. 3h–j, n–p also
shows the data analysis for 4.4 kDa TRITC-dextran.
Supplementary Fig. 4 shows an overlay of the EC50 curves for 5
independent experimental series of staurosporine (Supplementary
Fig. 4a, b) and aspirin (Supplementary Fig. 4c, d), based on both
150 kDa FITC-dextran (Supplementary Fig. 4a, c) and 4.4 kDa
TRITC-dextran (Supplementary Fig. 4b, d) analysis. Independent
experimental series were performed using cells at different
passage numbers, separate plates, and separate experimental
sessions. The high degree of similarity between the EC50 time
curves for the full replicate series are a powerful illustration of the
robustness of the method.
In parallel to fluorescence images, phase-contrast pictures
were taken at selected time points. An example of tube
morphology as a response to 96 h of staurosporine exposure is
included in the Supplementary Information (Supplementary
Fig. 5). Tubes are fully deteriorated for the highest concentration
staurosporine and damages can be observed for exposure to 30
µM staurosporine. For lower concentrations, tubes appear intact,
while fluorescence images show that barrier integrity is lost.
This indicates that loss of barrier function at higher concentra-
tions of staurosporine is primarily due to cell death. Dead cells are
flushed away by the perfusion flow.
For comparison, a similar experiment in a conventional
Transwell was performed, which revealed a lower sensitivity for
barrier disruption compared to the OrganoPlate, showing no
significant difference between controls and staurosporine exposed
wells after 4 h (Supplementary Fig. 6), while a clear effect is
already apparent in the OrganoPlate results. In addition to
improved morphological maturity of the 3D-perfused culture,
the increased sensitivity of the model can be attributed to a
decreased dead volume and higher surface-to-volume ratio of the
microfluidic system as compared to Transwell systems. In a
Transwell, the FITC-dextran was strongly diluted in the large
target volume when crossing the barrier. By contrast, in
OrganoPlates, the fluorescence is measured directly in the ECM
after crossing the epithelial membrane. Since no dilution step is
involved here, a much higher signal-to-noise ratio is obtained.
Sensitivity of the microfluidic assay is such that it can be used as a
binary assay, in which the exposure time at which leakage is
observed is indicative of the toxicity of the compound.
Real-time measurement. Figure 5 shows another concentration
response experiment with staurosporine, but this time the
OrganoPlate was continuously kept inside the microscope
throughout the experiment. A conditioned high content imager
was used to maintain appropriate CO2, temperature and
humidity. Flow was absent in this experiment, as the high content
imager did not provide rocking. As can be observed in fluorescent
images and quantification thereof, vehicle control tubes started
leaking after 6 to 8 h of imaging. This can most likely be attrib-
uted to suboptimal conditions, including a lack of perfusion flow.
Nevertheless, a clear concentration-response effect could be
observed. An EC50-time curve was extracted and overlaid in red
with the curve from the experiments with rocking in black (as
shown previously in Fig. 4g), showing similar curves for up to 8 h
Time (h)
Le
ak
ag
e 
sc
or
e 
(%
)
[S
tau
ros
po
rin
e
] (M
)
0 h 2 h 4 h 6 h 8 h 10 h
0
50
100
0 µM
0.4 µM
1.1 µM
3.3 µM
10 µM
30 µM
90 µM
0 µM 0.36 µM 1.1 µM 3.3 µM 10 µM 30 µM 90 µM No cells
Ti
m
e 
(h)
0
24
0
24T
im
e 
(h)
a
b
c
d
ex
cl
ex
cl
Time (h)
0 3 6 9 12
10–2
10–3
10–4
10–5
10–6
10–7
10–8
10–9
10–10
24 48 72 96 12
0
Static
95% CI
Flow
Fig. 5 Drug-induced loss of barrier integrity as a function of staurosporine
concentration measured in real-time. a, b Array of fluorescence
micrographs of the gel region showing distribution of the 150 kDa FITC-
Dextran (a) and 4.4 kDa TRITC-Dextran (b) over time and as a function of
compound concentration; the OrganoPlate was continuously kept in an
incubated automated microscope. Pictures were taken at 1 h intervals. One
data point was excluded for the fact that the tube appeared leaky at the first
time point (marked with “excl” in white). c The progression of the loss of
barrier function over time shows that untreated controls lose barrier
integrity at 6–8 h due to lack of flow. The plotted line is the mean of 3–5
technical replicate exposures and error bars depict the standard deviation.
d EC50 values over time for real-time measurement without flow and for
measurement in intervals with flow induced between measurement
(overlay with the graph of Fig. 4g). EC50 values with and without flow are
similar for the initial 8 h of measurement
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(Fig. 5c). The advantage of incubation in the microscope is that a
higher time resolution can be obtained.
In the experimental series of Figs. 4, 5, Supplementary Fig. 3
and Supplementary Fig. 4 10 OrganoPlates were used, comprising
a total of 357 gut tubes and 33 ECM-only negative controls in
total. Two tubes were excluded because of pipetting errors and 26
because of insufficient barrier function after 1 h, yielding 93% of
leak-tight tubes at the onset of drug exposure.
Discussion
In summary, we present a unique methodology for assessing the
barrier integrity of 40 leak-tight, polarized epithelial gut tubes in
parallel using HCI. It is for the first time that a comprehensive
method is presented to interrogate perfused epithelia tubules that
are exposed to an ECM. The system allows sensitive, real-time
interrogation of compound effects on barrier integrity, yielding
insight in both exposure concentration and exposure time effects.
The method has been robustly demonstrated for over 350 gut
tubes and over 20,000 datapoints, making this to our knowledge
the largest published Organ-on-a-Chip data set so far. The
method can be applied to other epithelia as well as translated to
disease models. The co-culture capabilities of the platform9 can
be explored to create complex tissue configurations, for example,
by incorporating mesenchymal and immune cells in the ECM
adjacent to the epithelial tubes. The system outperforms classical
techniques such as Transwell systems in terms of sensitivity, ease
of use and (multiplexed) readout flexibility, as well as reagent, cell
and time consumption. More importantly, it allows for the first
time non-expert end-users to adopt Organ-on-a-Chip technology
in their laboratories, without need for specific microfluidic skills
or dedicated equipment.
Methods
Cell culture. The human colon adenocarcinoma cell line Caco-2 (86010202,
Sigma-Aldrich) was cultured on T75 flasks in EMEM (No. 30-2003, ATCC), 10%
FBS (No. F4135, Sigma), 1% NEAA (No. 11140-050, Life Technologies) and 1%
penicillin/streptomycin (Sigma #P4333). Caco-2 cells between passage 45 and 60
were used for all experiments. Cells were routinely tested for mycoplasma con-
tamination and found negative.
OrganoPlate culture. OrganoPlate culture was performed using three-lane
OrganoPlates with 400 µm× 220 µm (w x h) channels (Mimetas BV, the Nether-
lands). Phaseguides had dimensions of 100 µm× 55 µm (w × h). Gel and perfusion
channels have a length of 9 mm and 13 mm, respectively. 2 µl of gel composed of 4
mg/ml Collagen I (AMSbio Cultrex 3D Collagen I Rat Tail, 5 mg/ml, Cat.
3447-020-01), 100 mM HEPES (Life Technologies, 15630–122) and 3.7 mg/ml
NaHCO3 (Sigma, Cat. S5761) was dispensed in the gel inlet and incubated 30–45
min at 37 °C. Caco-2 cells were trypsinized using 0.5% trypsin in PBS/EDTA
(Sigma, T3924), aliquoted and pelleted (5 min, 100 × g). The cells were applied
to the system by seeding 2 µl of 1 × 107 of cells/ml in the outlet of the top
medium channel. Subsequently, the OrganoPlate was put on the side for 20 min
to allow the cells to sediment against the ECM. This was followed by addition of
50 µl medium to the outlet of the top medium channel and the OrganoPlate was
again incubated on the side for 3–4 h at 37 °C to complete cell attachment. After
incubation, medium was added up to a total of 50 µl on both inlets and both
outlets. The OrganoPlate was placed horizontally in the incubator (37 °C 5% CO2)
on an interval rocker switching between a + 7° and −7° inclination every 8 min
(Mimetas Rocker Mini), allowing bi-directional flow. Medium (50 µl each on inlet
and outlet) was refreshed every 2–3 days.
Transwell culture. Caco-2 cells (60 × 103 cells per cm2) were seeded on Transwell
inserts (24-well, Transwell, Costar #3470-Clear, 0.4 µM pore size) and cultured
for 21 days in EMEM supplemented with 10% fetal calf serum (FCS), and
penicillin/streptomycin (Sigma #P4333). Medium was refreshed every 2–3 days,
both 100 µl on apical (insert) and 500 µl on basal side of the Transwell.
Immunohistochemistry. Caco-2 tubules were fixed with 3.7% formaldehyde
(Sigma No. 252549) in PBS (phosphate-buffered saline, Life Tech No. 20012068)
for 15 min washed twice for 5 min with PBS and permeabilized with 0.3% Triton
X-100 (Sigma # T8787) in PBS for 10 min. After washing with 4% FCS in PBS,
cells were incubated with blocking solution (2% FCS, 2% bovine serum albumin
(BSA) (Sigma # A2153), 0,1% Tween 20 (Sigma # P9416) in PBS) for 45 min.
Subsequently, cells were incubated with primary antibodies for 60 min or at 4 °C
overnight, washed three times, incubated with secondary antibodies for 30 min
and washed three times with 4% FCS in PBS. The following antibodies were used
for immunohistochemistry: Rabbit a-ZO-1 (Invitrogen No. 617300, 1:125),
Mouse a-acetylated tubulin (Sigma No. T6793, 1:2000), Rabbit a-ErbB1 (Novusbio
No. NBP-1-51439, 1:200), Mouse a-MRP-2 (Santa Cruz No. SC-59608, 100 µg/ml,
1:10), Rabbit a-Glut-2 (Santa Cruz No. SC-9117, 200 µg/ml, 1:20), Mouse a-Ezrin
(BD Transduction No. 610602, 1:50), Mouse a-ErbB2 (Thermo Scientific No.
MS-229-P0, 200 µg/ml, 1:20), Rabbit a-Occludin (ThermoFisher No. 71-1500, 0.25
mg/ml, 1:100), Rabbit isotype (Life Tech No. 86199), Mouse isotype (Life Tech No.
86599), Goat isotype (Life Tech No. 02-6202), Goat a-Rabbit AlexaFluor 488
(Thermo Scientific, No. A11008, 1:250), Goat a-Rabbit AlexaFluor 555 (Life Tech,
A21428, 1:250), Goat a-Mouse AlexaFluor 488 (Life Technologies, A11001, 1:250),
Goat a-Mouse AlexaFluor 555 (Life Tech, A21422, 1:250), Goat a-Mouse Alexa-
Fluor 647 (Life Tech, A-21236, 1:250), Donkey a-Rabbit AlexaFluor 647 (Life Tech,
A-31573, 1:250). After nuclear stain (DraQ5, Abcam No. ab108410 or DAPI, H-
1200, Vector Laboratories) cells were stored in PBS or Vectashield (H-1200,
VectorLaboratories). All steps were performed at room temperature (RT). Cells
were imaged with ImageXpress Micro XLS and Micro XLS-C HCI Systems
(Molecular Devices, US) and SP5 laser point scanning confocal microscope (Leica).
Compound exposure. Caco-2 cells in OrganoPlates and Transwells were exposed
to staurosporine or aspirin and barrier integrity was measured. Staurosporine was
tested separately on five experiments of Caco-2 tubes cultured in OrganoPlate
at passages: 48, 51, 53, 54, and 59. Aspirin was tested separately on three
experiments of Caco-2 tubes cultured in OrganoPlate at passages: 48, 51, and 56.
Cells were exposed for 125 h for interval measurements and for 24 h for real-time
measurements. Concentrations of aspirin were 0, 0.1, 0.33, 1.11, 3.67, 12.12, 40 mM
(Sigma No. A5376), and concentrations of staurosporine were 0, 0.4, 1.1, 3.3, 10,
30, 90 µM (Sigma No. S4400). Aspirin was dissolved in medium. Staurosporine was
dissolved in medium with 0.9% DMSO (Sigma, No. D8418) for 90 µM and 0.3% for
the other concentrations. Staurosporine preparations for the shorter-term exposure
also contained 9% tox medium for 90 μM staurosporine and 3% tox medium for
the other concentrations (500 ml of MEMα (Sigma No. M4526) with 6.25 ml of L-
glutamine (Sigma No. G7513), 6 ml Tox Supplement (Sigma No. MTOXRTSUP).
Barrier integrity assay in OrganoPlate. Medium in the apical perfusion
channel was replaced by medium containing 0.5 mg/ml FITC-dextran (150 kDa,
Sigma No. 46946) and TRITC-dextran (4.4 kDa, Sigma No. T1037) and increasing
concentrations of staurosporine or aspirin. Leakage of the fluorescent probe from
the lumen of the tubular structure into the ECM compartment was automatically
imaged using an ImageXpress XLS Micro HCI system at 37 °C and 5% CO2.
For long-term exposure, imaging was performed at 1-h intervals up to 12 h, and
from 24 to 36 h, and at 16, 35, 36, 48, 53, 60, 72, 82, 96, and 125 h. Between each
interval, the OrganoPlate was placed back into the incubator on the interval
rocker platform in order to maintain perfusion flow. For real-time measurement,
automatic imaging was performed every hour for 24 h without removing the
OrganoPlate from the HCI system. The ratio between the fluorescent signal in the
basal and apical region of the tube was analyzed using FiJi22.
Barrier integrity assay in Transwell. 14–21 h prior to start of the experiment,
media was changed to phenol-red free media (DMEM/F12 (Gibco, 11039-021),
10% FBS HI (Sigma, F4135), 1% NEAA (Life Tech, 11140050), 1% pen/strep
(Sigma, P4333)). At the start of the compound exposure, medium was replaced.
A total of 550 µl was added to the basolateral side, 250 µl of FITC-dextran solution
(0.125 mg/ml medium) mixed with the compound of choice was added to the
apical side. At each timepoint a 75 µl aliquot was collected from the basolateral
side. 75 µl of fresh medium was added to the basolateral side after the 2 h aspirin
timepoint. The fluorescence intensity was measured with a multi‐well plate
fluorimeter (Fluoroskan Ascent FL, Thermo Fisher) with excitation at 485 nm and
emission at 535 nm.
Statistics and data analysis. Barrier integrity assay images were analyzed using
FiJi22. Fluorescence intensities where measured in the apical and basal regions
of the tubes and the ratio between these was reported. Tubes that reached a 40%
fluorescent intensity ratio at first hour of measurement were considered non-leak
tight and discarded. GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA)
was used to generate Kaplan-Meier curves using the Survival Analysis – Survival
Curve function defining an event as showing a basal to apical fluorescence intensity
ratio over 40%. To prevent the overlapping data, curves were nudged by 1 data
point each for clarity. Curve difference was estimated using log-rank (Mantel–Cox)
test. Trend significance was evaluated using log-rank test.
Concentration-response curves were fitted using non-linear regression of
the logarithm of the compound concentration vs. the normalized fluorescence
assuming a top and bottom plateau at 0 and 100% and standard slope (hill slope=
1). The estimated EC50 values and 95% confidence interval were plotted vs. time.
Data availability. The data that support the findings of this study are available
from the corresponding author upon reasonable request.
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